Al-Dawaa Medical Services Company (TADAWUL:4163)

Saudi Arabia · Delayed Price · Currency is SAR

43.50

-0.44 (-1.00%)

Jul 2, 2026, 3:19 PM AST

-44.66% (1Y)

Market Cap	3.70B -42.9%
Revenue (ttm)	6.62B +0.3%
Net Income	238.84M -33.9%
EPS	2.81 -33.9%
Shares Out	85.00M
PE Ratio	15.48
Forward PE	12.08
Dividend	2.52 (5.79%)
Ex-Dividend Date	Jul 5, 2026

Volume	93,855
Open	43.94
Previous Close	43.94
Day's Range	43.42 - 43.94
52-Week Range	43.00 - 80.05
Beta	-0.02
Analysts	Hold
Price Target	58.31 (+34.05%)
Earnings Date	Aug 2, 2026

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain. The company offers medicines, perfumes, cosmetics, beauty tools, and other pharmaceutical products; and transportation and logistics services. It is also involved in online wholesale of pharmaceutical products, pharmaceutical agents, wholesale of pharmaceutical goods, related pharmacy activities, pharmaceutical warehousing activities, retail of medical equipment and other... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1993

Country Saudi Arabia

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4163

Full Company Profile

Financial Performance

In 2025, TADAWUL:4163's revenue was 6.74 billion, an increase of 4.37% compared to the previous year's 6.45 billion. Earnings were 321.76 million, a decrease of -8.44%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 4163 stock is "Hold." The 12-month stock price target is SAR 58.31, which is an increase of 34.05% from the latest price.

Price Target

SAR 58.31

(34.05% upside)

Analyst Consensus: Hold

Stock Forecasts